Conning Inc’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-162,848
Closed -$2.59M 575
2018
Q1
$2.59M Buy
+162,848
New +$3.03M 0.08% 158
2017
Q4
Sell
-340,679
Closed -$4.88M 602
2017
Q3
$4.88M Hold
340,679
0.17% 104
2017
Q2
$5.89M Buy
340,679
+230,910
+210% +$2.77M 0.21% 92
2017
Q1
$1.21M Hold
109,769
0.04% 244
2016
Q4
$1.59M Hold
109,769
0.06% 211
2016
Q3
$2.69M Hold
109,769
0.11% 149
2016
Q2
$2.21M Buy
109,769
+57,170
+109% +$1.62M 0.09% 170
2016
Q1
$1.38M Buy
+52,599
New +$3.89M 0.06% 218

Other funds holding BHC

Conning Inc's BHC Position: Q2 2018 in Review

Conning Inc sold out of Bausch Health (BHC) in Q2 2018, closing a stake of 162,848 shares — an estimated $2.59M sold.

Conning Inc first reported a position in BHC in Q1 2016 and held it in 8 quarters. The position peaked at $5.89M in Q2 2017. 311 funds tracked by Wall St. Rank hold BHC as of Q2 2018.

  • Conning Inc reported no remaining Bausch Health position as of Q2 2018 after selling out during the quarter.
  • Conning Inc sold 162,848 Bausch Health shares in Q2 2018, an estimated $2.59M.
  • Conning Inc first reported a position in Bausch Health in Q1 2016 and held it in 8 quarters.
  • Conning Inc's Bausch Health position peaked at $5.89M in Q2 2017.
  • 311 funds tracked by Wall St. Rank held Bausch Health as of Q2 2018.

Based on Conning Inc's 13F filing for Q2 2018, filed 25 Jul 2018.